Physician profile
Sukhdeep S Basra
NPI 1336474501
$168,173.73
in general payments reported to CMS, 2019-2025
26 companies · $57K in 2025
The $57K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,678 · 2020: $28K · 2021: $10K · 2022: $6,811 · 2023: $2,338 · 2024: $60K · 2025: $57K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $41K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $29K · Consulting Fee: $27K · Travel and Lodging: $14K · Food and Beverage: $8,331.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $41,340.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $29,110.00 |
| Consulting Fee | $26,775.50 |
| Travel and Lodging | $13,754.27 |
| Food and Beverage | $8,331.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $46,851.38 | 2023-2024 | Inpefa |
| Astrazeneca Pharmaceuticals LP | $42,276.17 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $34,419.31 | 2024-2025 | |
| Angiodynamics, INC. | $33,146.47 | 2022-2025 | Alphavac, Angiovac, Auryon Laser System 100-120 Vac |
| Abbott Laboratories | $5,787.73 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Triclip, Mitraclip |
| Edwards Lifesciences Corporation | $1,723.10 | 2021-2025 | Evoque, Sapien 3 Ultra Resilia, Pascal |
| Endovascular Engineering INC. | $1,376.93 | 2024-2025 | Helo Thrombectomy System |
| Medtronic Vascular, INC. | $660.13 | 2019 | |
| Boston Scientific Corporation | $591.39 | 2019 | |
| Medtronic, INC. | $444.06 | 2024-2025 | Corevalve Evolut R, Apollotm |
| Inari Medical, INC. | $203.95 | 2019-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Novartis Pharmaceuticals Corporation | $169.39 | 2021-2025 | |
| Fujifilm Healthcare Americas Corporation | $121.44 | 2022 | |
| Janssen Pharmaceuticals, INC | $81.01 | 2019-2023 | Xarelto |
| Abiomed | $75.62 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $44.66 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $33.05 | 2022 | |
| Imperative Care, INC | $27.80 | 2025 | Symphony Catheter |
| Analog Devices INC. | $24.95 | 2025 | Sensinel Cpm Wearable |
| Canon Medical Systems USA, INC. | $23.63 | 2024 | Interventional Angiography System |
| Medicomp INC | $23.58 | 2019 | |
| Chiesi USA, INC. | $18.93 | 2019 | |
| Scpharmaceuticals INC. | $17.43 | 2023 | |
| Amgen INC. | $16.50 | 2023 | Repatha |
| Pfizer INC. | $12.47 | 2019 | |
| Penumbra, INC. | $2.65 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sukhdeep Basra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.